Kolexia
Salas Sebastien Oncologie médicale
Salas Sebastien
Oncologie médicale
Hôpital La Timone
Marseille, France
237 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Carcinomes Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Fibromatose agressive Récidive tumorale locale Tumeurs de la tête et du cou Fibrome Métastase tumorale

Collaborateurs

Voir plus
Duffaud Florence
Duffaud Florence
Hôpital La Timone, Marseille, France
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Penel Nicolas
Penel Nicolas
Centre Oscar-Lambret, Lille, France
Italiano Antoine
Italiano Antoine
Institut Bergonié, Bordeaux, France

Industries

Voir plus
MSD
9 collaboration(s)
Dernière en 2023
BMS
8 collaboration(s)
Dernière en 2021
Merck-Serono
3 collaboration(s)
Dernière en 2021
Novartis
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
innovaTV 207: Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors
Essai Clinique (Seagen)   15 mars 2024
iintune-1: An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
Essai Clinique (Takeda Pharmaceutical)   07 mars 2024
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION): A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
Essai Clinique (Emd Serono)   05 mars 2024
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors: Phase 1/2 Dose Escalation and Cohort Expansion Study Evaluating MCLA-158 (Petosemtamab) as Single Agent or in Combination in Advanced Solid Tumors
Essai Clinique (Merus N.V.)   01 mars 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
QUALIOR: Study Evaluating the Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program, for Metastatic Cancer Patients Receiving Oral Targeted Therapy: The UNICANCER SdS 01 QUALIOR Study
Essai Clinique (Unicancer)   07 novembre 2023
Laser Hair Removal for Intraoral Flaps: A Review.
Facial plastic surgery & aesthetic medicine   25 octobre 2023
PembroMetaRT: Randomized Trial of Loco-regional Radiotherapy Added to Pembrolizumab Alone or With Chemotherapy Versus Systemic Treatment Alone for Patients With Newly Diagnosed Head and Neck Squamous Cell Carcinoma With Synchronous Metastases
Essai Clinique (Unicancer)   12 octobre 2023
940P Salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck included in the phase II TOPNIVO trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023